Thymoma and Autoimmune Neurological Disorders

A Search for Missing Links in Pathogenesis
  • Angela Vincent
  • Nick Willcox
  • Ioannis Roxanis
  • John Newsom-Davis
  • Cal McLennan
  • David Beeson

Abstract

It has long been recognised that autoimmunity may be associated with particular tumours, and the regular co-occurrence of myasthenia gravis (MG) with thymoma is well established. In this brief review we will summarise some of the evidence for thymoma-associated antibodies in myasthenia, and in other neurological disorders, and discuss the possible relationship between the tumour, these antibodies and the initiation of the disease.

Keywords

Small Cell Lung Cancer Limbic Encephalitis Determinant Spreading Thymic Tumour Lambert Eaton Myasthenic Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Souadjian JV, Enriquez P, Silverstein MN, Pepin J-M. The spectrum of diseases associated with thymoma. Arch Intern Med 134:374–379, 1974.PubMedCrossRefGoogle Scholar
  2. 2.
    Drachman DB. Myasthenia gravis. 1994. New England J Med 330:1797–1810.CrossRefGoogle Scholar
  3. 3.
    Vincent A, Whiting PJ, Schluep M et al. 1987. Antibody heterogeneity and specificity in myasthenia gravis. Ann NY Acad Sci 505:326–332.CrossRefGoogle Scholar
  4. 4.
    Karlin A, Akabas MH. 1995. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15:1231–1244.PubMedCrossRefGoogle Scholar
  5. 5.
    Tzartos SJ, Lindstrom JM. 1980. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc Natl Acad Sci USA 77:755–759.PubMedCrossRefGoogle Scholar
  6. 6.
    Tzartos SJ, Seybold ME, Lindstrom JM. 1982. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci USA 79:188–192.PubMedCrossRefGoogle Scholar
  7. 7.
    Tzartos SJ, Barkas T, Cung MT, et al. 1991. The main immunogenic region of the acetylcholine receptor: structure and role in myasthenia gravis. Autoimmunity 8:259–270.PubMedCrossRefGoogle Scholar
  8. 8.
    Compston DAS, Vincent A, Newsom-Davis J, Batchelor JR. 1980. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain, 103, 579–601.PubMedCrossRefGoogle Scholar
  9. 9.
    Schluep M, Willcox N, Vincent A, Dhoot GK, Newsom-Davis J. 1987. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann Neurol 22:212–222.PubMedCrossRefGoogle Scholar
  10. 10.
    Scadding GK, Vincent A, Newsom-Davis J, Henry K. 1981. Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology 31:935–943.PubMedCrossRefGoogle Scholar
  11. 11.
    Heidenreich, F., A. Vincent, N. Willcox and J. Newsom-Davis. 1988. Anti-acetylcholine receptor antibody specificities in serum and in thymic culture supernatants from myasthenia gravis patients. Neurology 38:1784–1788.PubMedCrossRefGoogle Scholar
  12. 12.
    Vincent A, Newsom-Davis J, Newton P, Beck N. 1983. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis. Neurology 33:1276–1282.PubMedCrossRefGoogle Scholar
  13. 13.
    Fujii Y, Monden Y, Nakahara K, Hashimoto J, Kawashima Y. 1984. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma. Neurology 34; 1182–116.PubMedCrossRefGoogle Scholar
  14. 14.
    Willcox N, Schluep M, Ritter MA, Schurman HJ, Newsom-Davis J, Christensson B. Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset? Am J Pathol 1987; 127:447–460.PubMedGoogle Scholar
  15. 15.
    Somnier FE. Exacerbation of myasthenia gravis after removal of thymoma. Acta Neurol Scand 1994; 90:56–66.PubMedCrossRefGoogle Scholar
  16. 16.
    Gilhus N-E, Aarli JA, Christensson B, Matre R. Rabbit Antiserum to a Citric Acid Extract of Human Skeletal Muscle Staining Thymomas from Myasthenia Gravis Patients. J Neuroimmunol 1984, 7: 55–64.PubMedCrossRefGoogle Scholar
  17. 17.
    Kirchner T, Hoppe F, Schalke B, Muller-Hermelink HK. 1988. Microenvironment of thymic myoid cells in myasthenia gravis. Virch Archiv B Cell Pathol 54:295–302.CrossRefGoogle Scholar
  18. 18.
    Marx A, Willisch A, Schultz A, Greiner A, Magi B, Pallini Vi, Schalke B et al. Expression of neurofilaments and of a titin epitope in thymic epithelial tumours. Implications for the pathogenesis of myasthenia gravis. Am J Pathol 1996; 148:1839–1850.PubMedGoogle Scholar
  19. 19.
    Gilhus NE, Willcox N, Harcourt G, Nagvekar N, Beeson D, Vincent A, Newsom Davis J. 1995. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. J Neuroimmunol 56:65–76.PubMedCrossRefGoogle Scholar
  20. 20.
    Geuder KI, Marx A, Witzemann V, Schalke B, Kirchner T, Müller-Hermelink HK. 1992. Genomic Organization and Lack of Transcription of the Njcotinic Acetylcholine Receptor Subunit Genes in Myasthenia Gravis-Associated Thymoma. Lab Invest 66:452–458.PubMedGoogle Scholar
  21. 21.
    Vincent A 1980. Immunology of acetylcholine receptors in relation to myasthenia gravis. Physiol Rev 60, 756–824.PubMedGoogle Scholar
  22. 22.
    Jacobson, L, Nagvekar, N, Vincent, A, Willcox, N, Newsom-Davis, J. Is the AChR α373–380 sequence a T or B cell epitope in thymoma associated-myasthenia gravis? Neuromusc Disord 4:S34, 1994.(Abstract)Google Scholar
  23. 23.
    Sommer N, Willcox N, Harcourt GC, Newsom Davis J. 1990. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann Neurol 28:312–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Osborn M, Marx A, Kirchner T, Tzartos SJ, Plessman W, Weber K. 1992. A Shared Epitope in the Acetylcholine Receptor-a Subunit and Fast Troponin I of Skeletal Muscle. Am J Pathol 140:1215–1223.PubMedGoogle Scholar
  25. 25.
    Marx A; Kirchner T; Greiner A; Muller Hermelink HK; Schalke B; Osborn M. 1992. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis. Lancet 339:707–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Williams CL, Lennon VA. 1986. Thymic B Lymphocyte Clones from Patients with Myasthenia Gravis Secrete Monoclonal Striational Autoantibodies Reacting with Myosin, a Actinin, or Actin. J Exp Med 164:1043–1059.PubMedCrossRefGoogle Scholar
  27. 27.
    Kaminski HJ, Fenstermaker RA, Abdul Karim FW, Clayman J, Ruff RL. 1993. Acetylcholine receptor subunit gene expression in thymic tissue. Muscle Nerve 16:1332–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Vincent A, Newsom-Davis J. 1982. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalised myasthenia or disease restricted to ocular muscles. Clin Exp Immunol 49:257–265.PubMedGoogle Scholar
  29. 29.
    Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant Spreading and the Dynamics of the Autoimmune T-Cell Repertoire. Immunology Today, 1993, 14: 203–208.PubMedCrossRefGoogle Scholar
  30. 30.
    Vincent A, Jacobson L, Shillito P. 1994. Response to human acetylcholine receptor α 138-199: determinant spreading initiates autoimmunity to self-antigen in rabbits. Immunol Lett 39:269–275.PubMedCrossRefGoogle Scholar
  31. 31.
    Newsom-Davis J, Mills KR. 1993. Immunological associations of acquired neuromyotonia (Isaacs’ syndrome). Report of five cases and literature review. Brain 116:453–469.PubMedCrossRefGoogle Scholar
  32. 32.
    Shillito P, Molenaar PC, Vincent A, et al 1995. Acquired neuromyotonia: evidence for autoantibodies against K+ channels of peripheral nerves. Ann Neurol. 38; 714–722.PubMedCrossRefGoogle Scholar
  33. 33.
    Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, Vicari AM. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and Type 1 diabetes mellitus. N Engl J Med 318:1012–1020, 1988.PubMedCrossRefGoogle Scholar
  34. 34.
    O’Neill JH, Murray NM, Newsom-Davis J. 1988. The Lambert-Eaton myasthenie syndrome. A review of 50 cases. Brain 111:577–596.PubMedCrossRefGoogle Scholar
  35. 35.
    Roberts A, Perera S, Lang B, Vincent A, Newsom-Davis J. 1985. Paraneoplastic myasthenie syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature 317:737–739.PubMedCrossRefGoogle Scholar
  36. 36.
    Motomura M, Johnston I, Lang B, Vincent A, Newsom-Davis J. 1995. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 58:85–87.PubMedCrossRefGoogle Scholar
  37. 37.
    Lennon VA, Kryzer TJ, Griesmann GE, O’Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH. 1995. Calcium channel antibodies in the Lambert Eaton myasthenic syndrome and other paraneoplastic syndromes. New Eng J Med 332:1467–1474.PubMedCrossRefGoogle Scholar
  38. 38.
    Chalk CH, Murray NM, Newsom-Davis J, O’Neill JH, Spiro SG. 1990. Response of the Lambert-Eaton myasthenie syndrome to treatment of associated small-cell lung carcinoma. Neurology 40:1552–1556.PubMedCrossRefGoogle Scholar
  39. 39.
    Antoine JC, Honnorat J, Thomas Angerion C, Aguera M, Absi L, Fournel P, Michel D. Limbic encephalitis and immunological perturbations in two patients with thymoma. J Neurol Neursurg Psychiatry 1995 58; 706–710.CrossRefGoogle Scholar
  40. 40.
    Morris CS, Esiri MM, Marx A, Newsom-Davis J. 1992. Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenie syndrome. Am J Pathol 140:839–845.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Angela Vincent
    • 1
  • Nick Willcox
    • 1
  • Ioannis Roxanis
    • 1
  • John Newsom-Davis
    • 1
  • Cal McLennan
    • 1
  • David Beeson
    • 1
  1. 1.Neuroscience Group, Institute of Molecular MedicineJohn Radcliffe HospitalOxfordEngland

Personalised recommendations